000 01233 a2200349 4500
005 20250512235459.0
264 0 _c19830920
008 198309s 0 0 eng d
022 _a0009-9236
024 7 _a10.1038/clpt.1983.154
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrater, D C
245 0 0 _aBumetanide and furosemide.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cAug 1983
300 _a207-13 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Oral
650 0 4 _aBiological Availability
650 0 4 _aBumetanide
_xadministration & dosage
650 0 4 _aDiuretics
_xurine
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFurosemide
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aKinetics
700 1 _aChennavasin, P
700 1 _aDay, B
700 1 _aBurdette, A
700 1 _aAnderson, S
773 0 _tClinical pharmacology and therapeutics
_gvol. 34
_gno. 2
_gp. 207-13
856 4 0 _uhttps://doi.org/10.1038/clpt.1983.154
_zAvailable from publisher's website
999 _c6872144
_d6872144